Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials.
<h4>Objective and design</h4>Gliclazide has been associated with a low risk of hypoglycemic episodes and beneficial long-term cardiovascular safety in observational cohorts. The aim of this study was to assess in a systematic review and meta-analysis of randomized controlled trials the s...
Saved in:
| Main Authors: | Gijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, Peter R van Dijk, Klaas H Groenier, Rijk O B Gans, Sebastiaan T Houweling, Henk J G Bilo, Nanne Kleefstra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0082880 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).
by: Esther G Gerrits, et al.
Published: (2014-01-01) -
Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
by: Yvonne Roelofsen, et al.
Published: (2016-01-01) -
Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review
by: Rifika Bansal, et al.
Published: (2025-05-01) -
RP-HPLC Method for the Simultaneous Estimation of Rosiglitazone and Gliclazide in Tablets
by: G. Rathinavel, et al.
Published: (2009-01-01) -
Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials
by: Gerritje S. Mijnhout, et al.
Published: (2012-01-01)